» Authors » Tomas Chytka

Tomas Chytka

Explore the profile of Tomas Chytka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 107
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamackova L, Novotny Jr J, Simonova G, Liscak R, Chytka T
Stereotact Funct Neurosurg . 2024 Jan; 102(2):65-73. PMID: 38198760
Introduction: It is a normal procedure to avoid the application of ionizing radiation during pregnancy. In very rare occasions, treatment can be performed, but doses to the fetus must be...
2.
Maragkos G, Mantziaris G, Pikis S, Chytka T, Liscak R, Peker S, et al.
Neurosurgery . 2023 Nov; 93(6):1407-1414. PMID: 37966247
Background And Objectives: There is conflicting evidence on the significance of adrenocorticotrophic hormone (ACTH) staining in the prognosis of nonfunctioning pituitary neuroendocrine tumors (NFpitNETs). The objective of this study was...
3.
Bin-Alamer O, Pikis S, Mantziaris G, Abdulbaki A, Mallela A, Lu V, et al.
Neurosurgery . 2023 Apr; 93(4):892-900. PMID: 37052386
Background: Clival chordomas are challenging because of their proximity to critical neurovascular structures. Stereotactic radiosurgery (SRS) has been proven effective with minimal adverse effects. Objective: To compare the outcomes of...
4.
Bin-Alamer O, Faramand A, Alarifi N, Wei Z, Mallela A, Lu V, et al.
Neurosurgery . 2023 Mar; 92(5):934-944. PMID: 36861994
Background: Vestibular schwannomas (VSs) related to neurofibromatosis type 2 (NF2) are challenging tumors. The increasing use of stereotactic radiosurgery (SRS) necessitates further investigations of its role and safety. Objective: To...
5.
Mantziaris G, Pikis S, Chytka T, Liscak R, Sheehan K, Sheehan D, et al.
J Neurosurg . 2022 Nov; 138(6):1662-1668. PMID: 36401547
Objective: Radiological progression occurs in 50%-60% of residual nonfunctioning pituitary adenomas (NFPAs). Stereotactic radiosurgery (SRS) is a safe and effective management option for residual NFPAs, but there is no consensus...
6.
Ruiz-Garcia H, Trifiletti D, Mohammed N, Hung Y, Xu Z, Chytka T, et al.
J Neurol Surg B Skull Base . 2022 Jul; 83(Suppl 2):e173-e180. PMID: 35832959
 Meningiomas are the second most common tumors in neurofibromatosis type 2 (NF-2). Microsurgery is challenging in NF-2 patients presenting with skull base meningiomas due to the intrinsic risks and need...
7.
Pikis S, Mantziaris G, Peker S, Samanci Y, Nabeel A, Reda W, et al.
J Neurosurg . 2022 Feb; 137(4):977-984. PMID: 35120328
Objective: The object of this study was to evaluate the safety, efficacy, and long-term outcomes of stereotactic radiosurgery (SRS) in the management of intracranial chordomas. Methods: This retrospective multicenter study...
8.
Asuzu D, Bunevicius A, Anand R, Suleiman M, Nabeel A, Reda W, et al.
J Neurosurg . 2021 Sep; 136(4):1070-1076. PMID: 34560648
Objective: Resection of meningiomas in direct contact with the anterior optic apparatus carries risk of injury to the visual pathway. Stereotactic radiosurgery (SRS) offers a minimally invasive alternative. However, its...
9.
Pomeraniec I, Xu Z, Lee C, Yang H, Chytka T, Liscak R, et al.
J Neurosurg . 2021 Sep; 136(3):813-821. PMID: 34560630
Objective: Stereotactic radiosurgery (SRS) provides a safe and effective therapeutic modality for patients with pituitary adenomas. The mechanism of delayed endocrine deficits based on targeted radiation to the hypothalamic-pituitary axis...
10.
Seymour Z, Chan J, McDermott M, Grills I, Ye H, Kano H, et al.
J Neurosurg . 2021 Aug; 136(2):503-511. PMID: 34450589
Objective: The optimal treatment paradigm for large arteriovenous malformations (AVMs) is controversial. One approach is volume-staged stereotactic radiosurgery (VS-SRS). The authors previously reported efficacy of VS-SRS for large AVMs in...